These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 12854054
1. The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis. Murata E, Sharmin S, Shiota H, Shiota M, Yano M, Kido H. Curr Eye Res; 2003 May; 26(5):271-6. PubMed ID: 12854054 [Abstract] [Full Text] [Related]
3. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor. Pemberton AD, Huntley JF, Miller HR. Biochim Biophys Acta; 1998 Jan 08; 1379(1):29-34. PubMed ID: 9468329 [Abstract] [Full Text] [Related]
4. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H. Exp Eye Res; 2010 Jul 08; 91(1):85-91. PubMed ID: 20412793 [Abstract] [Full Text] [Related]
5. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction. Forteza RM, Ahmed A, Lee T, Abraham WM. Pulm Pharmacol Ther; 2001 Jul 08; 14(2):107-10. PubMed ID: 11273791 [Abstract] [Full Text] [Related]
8. Involvement of chymase in allergic conjunctivitis of guinea pigs. Nabe T, Kijitani Y, Kitagawa Y, Sakano E, Ueno T, Fujii M, Nakao S, Sakai M, Takai S. Exp Eye Res; 2013 Aug 08; 113():74-9. PubMed ID: 23726880 [Abstract] [Full Text] [Related]
10. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG. Ophthalmology; 1997 May 08; 104(5):849-53. PubMed ID: 9160033 [Abstract] [Full Text] [Related]
11. Tear tryptase levels and allergic conjunctivitis. Magrini L, Bonini S, Centofanti M, Schiavone M, Bonini S. Allergy; 1996 Aug 08; 51(8):577-81. PubMed ID: 8874662 [Abstract] [Full Text] [Related]
12. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis. Schoch C. J Ocul Pharmacol Ther; 2003 Apr 08; 19(2):153-9. PubMed ID: 12804060 [Abstract] [Full Text] [Related]
13. Anti VLA-4 monoclonal antibody inhibits eosinophil infiltration in allergic conjunctivitis model of guinea pig. Ebihara N, Yokoyama T, Kimura T, Nakayasu K, Okumura K, Kanai A, Ra C. Curr Eye Res; 1999 Jul 08; 19(1):20-5. PubMed ID: 10415453 [Abstract] [Full Text] [Related]
14. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. Kato M, Imoto K, Miyake H, Oda T, Miyaji S, Nakamura M. J Pharmacol Sci; 2004 Aug 08; 95(4):435-42. PubMed ID: 15286429 [Abstract] [Full Text] [Related]
18. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Rao NV, Marshall BC, Gray BH, Hoidal JR. Am J Respir Cell Mol Biol; 1993 Jun 08; 8(6):612-6. PubMed ID: 8100709 [Abstract] [Full Text] [Related]
19. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease. Belkowski SM, Boot JD, Mascelli MA, Diamant Z, de Garavilla L, Hertzog B, Polkovitch D, Towers M, Batheja A, D'Andrea MR. Clin Exp Allergy; 2009 Aug 08; 39(8):1179-86. PubMed ID: 19400896 [Abstract] [Full Text] [Related]
20. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation. Westin U, Polling A, Ljungkrantz I, Ohlsson K. Biol Chem; 1999 Apr 08; 380(4):489-93. PubMed ID: 10355635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]